Investigation of angucycline compounds as potential drug candidates against SARS Cov-2 main protease using docking and molecular dynamic approaches

ABSTRACT: The emerged Coronavirus disease (COVID-19) causes severe or even fatal respiratory tract infection, and to date there is no FDA-approved therapeutics or effective treatment available to effectively combat this viral infection. This urgent situation is an attractive research area in the fie...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Bustany, Hazem Abbas, Ercan, Selami, Ince, Ebru, Pirinccioglu, Necmettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035615/
https://www.ncbi.nlm.nih.gov/pubmed/33837893
http://dx.doi.org/10.1007/s11030-021-10219-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035615/
https://www.ncbi.nlm.nih.gov/pubmed/33837893
http://dx.doi.org/10.1007/s11030-021-10219-1

Ejemplares similares